These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15893708)

  • 21. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.
    Druschky A; Hilz MJ; Platsch G; Radespiel-Tröger M; Druschky K; Kuwert T; Neundörfer B
    J Neurol Sci; 2000 Apr; 175(1):3-12. PubMed ID: 10785250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
    Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation with sympathetic skin response,
    Ozawa M; Morishima R; Shimizu T; Takahashi K
    Neurophysiol Clin; 2024 Jul; 54(4):102956. PubMed ID: 38422587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
    Rascol O; Schelosky L
    Mov Disord; 2009; 24 Suppl 2():S732-41. PubMed ID: 19877202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].
    Satoh A; Serita T; Tsujihata M
    Nihon Rinsho; 1997 Jan; 55(1):202-6. PubMed ID: 9014450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
    Marini C; Bandettini di Poggio M; Pomposelli E; Marchese R; Nobili F; Morbelli SD; Villa G; Abbruzzese G; Sambuceti G
    Clin Nucl Med; 2010 May; 35(5):311-6. PubMed ID: 20395701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
    Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
    Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIBG myocardial scintigraphy in progressive supranuclear palsy.
    Kamada T; Miura S; Kida H; Irie KI; Yamanishi Y; Hoshino T; Taniwaki T
    J Neurol Sci; 2019 Jan; 396():3-7. PubMed ID: 30391822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.
    Choi MH; Yoon JH; Yong SW
    J Neurol Sci; 2017 Oct; 381():291-295. PubMed ID: 28991700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity and specificity of cardiac
    Kawazoe M; Arima H; Maeda T; Tsuji M; Mishima T; Fujioka S; Tsugawa J; Tsuboi Y
    J Neurol Sci; 2019 Dec; 407():116409. PubMed ID: 31706063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.
    Nakae I; Hayashi H; Mitsunami K; Horie M
    Ann Nucl Med; 2013 Oct; 27(8):737-47. PubMed ID: 23728513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.
    Yoshita M
    J Neurol Sci; 1998 Feb; 155(1):60-7. PubMed ID: 9562324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac 123I-MIBG scintigraphy in patients with essential tremor.
    Lee PH; Kim JW; Bang OY; Joo IS; Yoon SN; Huh K
    Mov Disord; 2006 Aug; 21(8):1235-8. PubMed ID: 16671077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
    Gabilondo I; Llorens V; Rodriguez T; Fernández M; Concha TP; Acera M; Tijero B; Murueta-Goyena A; Del Pino R; Cortés J; Gómez-Esteban JC
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):376-384. PubMed ID: 30324423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
    Taki J; Yoshita M; Yamada M; Tonami N
    Ann Nucl Med; 2004 Sep; 18(6):453-61. PubMed ID: 15515743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
    Kashihara K; Ohno M; Kawada S; Okumura Y
    J Nucl Med; 2006 Jul; 47(7):1099-101. PubMed ID: 16818943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.